Ex Parte HOLLIS et al - Page 6


                 Appeal No. 2003-1594                                                          Page 6                    
                 Application No.  08/970,266                                                                             

                        Yamawaki-Kataoka is cited for teaching the complete nucleotide                                   
                 sequence of mouse immunoglobulin gamma 2A gene.  The rejection concludes:                               
                        From the knowledge of the murine immunoglobulin [gamma 2A]                                       
                        gene sequence and the teachings of [Fell A or Fell B] it would have                              
                        been obvious to one skilled in the art at the time the invention was                             
                        made to modify the vectors of [Fell A or Fell B] to include the IgG2A                            
                        sequence [to] [sic] permit locus-specific homologous recombination                               
                        into the immunoglobulin [gamma 2A] gene locus.  The combination                                  
                        of [Fell A or Fell B] with Yamawaki-Kataoka [ ] do not teach the use                             
                        of NS/O cells but instead [Fell B] use murine hybridoma cells                                    
                        substantially similar to NS/O cells.  However, as admitted by the                                
                        specification applicant’s admitted prior art at page 3 of the                                    
                        specification “NS/O” cells Galfre [ ] teach NS/O cells.  Therefore it                            
                        would have been prima facie obvious to a person of ordinary skill in                             
                        the art at the time the invention was made to apply the teachings of                             
                        [Fell A or B] to that of Yamawaki-Kataoka [ ] to obtain a method                                 
                        using an expression vector for the expression of recombinant                                     
                        immunoglobulin genes in NS/O cells with the vector named                                         
                        pIgG2A.  A person of ordinary skill in the art would have been                                   
                        motivated to produce the claimed method to express                                               
                        immunoglobulin genes of interest.                                                                
                 Id. at 7.                                                                                               
                        The burden is on the examiner to set forth a prima facie case of                                 
                 obviousness. See In re Alton, 76 F.3d 1168, 1175, 37 USPQ2d 1578, 1581                                  
                 (Fed. Cir. 1996).  With respect to an obviousness rejection based on a                                  
                 combination of references, as the court has stated, “virtually all [inventions] are                     
                 combinations of old elements.”  Environmental Designs, Ltd. V. Union Oil Co.,                           
                 713 693, 698, 218 USPQ 865, 870 (Fed. Cir. 1983); see also Richdel, Inc. v.                             
                 Sunspool Corp., 714 F.2d 1573, 1579-80, 219 U.S.P.Q. (BNA) 8, 12 (Fed. Cir.                             
                 1983) (“Most, if not all, inventions are combinations and mostly of old                                 









Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007